FGF21 and obesity due to melanocortin 4 receptor deficiency: Previously, metformin was found to downregulate the levels of obesity-related factors, including cholesterol and LDL, but to promote FGF21 expression in obese mice.23 Since FGF21 has been shown to be a key regulator of obesity,14 enhancing FGF21 expression has great potential therapeutic efficacy.